# Bone metastases in pheochromocytomas and paragangliomas: a narrative review of presentation, diagnosis and management

## TL;DR

This review discusses bone metastases in pheochromocytomas and paragangliomas, focusing on their impact, detection, and management challenges.

## Contribution

The paper provides a comprehensive narrative review of bone metastases in metastatic pheochromocytomas and paragangliomas, emphasizing clinical implications and management strategies.

## Key findings

- Bone metastases are common in malignant pheochromocytomas and paragangliomas, leading to significant skeletal-related events.
- Improved imaging techniques aid in detection, but multidisciplinary approaches are needed for optimal management.
- Understanding biological mechanisms and risk factors is crucial for preventing complications and improving patient outcomes.

## Abstract

Bone metastases (BM) are a frequent and clinically relevant manifestation in patients with metastatic pheochromocytomas and paragangliomas (mPPGL).

This narrative review aims to summarize the current understanding of the pathophysiology, epidemiology, clinical presentation, complications, quality of life impact, and management of BM in mPPGL.

Bone and lymph nodes are among the most common metastatic sites in malignant PPGL. Skeletal involvement—particularly in paragangliomas—is associated with a high incidence of skeletal-related events (SREs), including pathological fractures, spinal cord compression, and pain. These complications lead to reduced mobility, loss of independence, and decreased survival. Advances in functional and anatomical imaging have improved detection, but optimal management remains complex and requires a multidisciplinary approach.

Recognizing patients at higher risk and understanding the biological mechanisms underlying bone dissemination are essential to optimize diagnosis, prevent SREs, and improve outcomes in this rare and challenging disease.